BASELINE TOTAL METABOLIC TUMOUR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.50-52
Main Authors: Trněný, M., Canales Ruiz, I., Martelli, M., Sehn, L.H., Vitolo, U., Brown, H., Nielsen, T., Sellam, G., Kostakoglu, L.
Format: Article
Language:English
Subjects:
Thermal resistance
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.20_2629